Warning! GuruFocus has detected 2 Severe warning signs with OPK. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for OPK (OPKO Health Inc) from 1995 to May 07 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. OPKO Health stock (OPK) PE ratio as of May 07 2021 is 21.05. More Details
OPKO Health PE Ratio (TTM) Historical Data
View and export this data going back to 1995. Start your Free Trial
OPKO Health PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
4400 Biscayne Boulevard, Miami, FL, USA, 33137
Opko Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a specialty active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.